Literature DB >> 7051006

Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate.

P Machy, J Barbet, L D Leserman.   

Abstract

Antibody-bearing fluorescent liposomes containing methotrexate became bound to cells expressing determinants recognized by the antibody. The number of bound liposomes could be evaluated by fluorometry, and the internalization of liposomes was evaluated by the methotrexate-mediated inhibition of radio-labeled deoxyuridine incorporation. The effect of methotrexate transferred from the liposomes into the cells was a function not of the number of liposomes bound but of the nature of the cells and of the target molecules. Liposomes bearing antibodies with specificity for the H-2K or Mr 94,000 and 180,000 molecules were much more effective at drug delivery into T than B cells, even though these determinants were expressed by both cell types. B cells were more sensitive to the effect of methotrexate in anti-H-2 I-A and I-E liposomes than in anti-H-2K liposomes. Inhibition of the methotrexate effect by NH4Cl suggested that methotrexate entered the cell by endocytosis of the liposomes. The results are consistent with differential internalization of H-2K, I-A, I-E, and Mr 94,000 and 180,000 cell surface molecules by mitogen-stimulated T and B cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051006      PMCID: PMC346594          DOI: 10.1073/pnas.79.13.4148

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Turnover and shedding of Ia antigens by murine spleen cells in culture.

Authors:  S G Emerson; R E Cone
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

3.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

4.  Influenza virus infection of mouse lymphoblasts alters the binding affinity of anti-H-2 antibody: requirement for viral neuraminidase.

Authors:  P A Liberti; C J Hackett; B A Askonas
Journal:  Eur J Immunol       Date:  1979-10       Impact factor: 5.532

5.  Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker.

Authors:  J N Weinstein; S Yoshikami; P Henkart; R Blumenthal; W A Hagins
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

Review 6.  Lymphocyte receptors for immunoglobulin.

Authors:  H B Dickler
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

7.  Cell-specific drug transfer from liposomes bearing monoclonal antibodies.

Authors:  L D Leserman; P Machy; J Barbet
Journal:  Nature       Date:  1981 Sep 17-23       Impact factor: 49.962

8.  Clonal analysis of B- and T-cell responses to Ia antigens. I. Topology of epitope regions on I-Ak and I-Ek molecules analyzed with 35 monoclonal alloantibodies.

Authors:  M Pierres; C Devaux; M Dosseto; S Marchetto
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

9.  Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition.

Authors:  S G Emerson; D B Murphy; R E Cone
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities.

Authors:  C E Hayes; F H Bach
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Transport and expression of HLA class-II glycoproteins.

Authors:  P Cresswell; J S Blum; J E Davis; M S Marks
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes.

Authors:  F Dromer; J Barbet; J Bolard; J Charreire; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells.

Authors:  S Yemul; C Berger; M Katz; A Estabrook; R Edelson; H Bayley
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Gene transfer from targeted liposomes to specific lymphoid cells by electroporation.

Authors:  P Machy; F Lewis; L McMillan; Z L Jonak
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.

Authors:  A G Gray; J Morgan; D C Linch; E R Huehns
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

6.  Selective killing of T lymphocytes by phototoxic liposomes.

Authors:  S Yemul; C Berger; A Estabrook; S Suarez; R Edelson; H Bayley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  A novel H-2K splice form: predictions for other alternative H-2 splicing events.

Authors:  J M Vogel; R Y Morse; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 8.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

9.  Endocytosis of liposomes bound to cell surface proteins measured by flow cytofluorometry.

Authors:  A Truneh; Z Mishal; J Barbet; P Machy; L D Leserman
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

10.  Mechanism for amyloid precursor-like protein 2 enhancement of major histocompatibility complex class I molecule degradation.

Authors:  Amit Tuli; Mahak Sharma; Haley L Capek; Naava Naslavsky; Steve Caplan; Joyce C Solheim
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.